Autolus Therapeutics (NASDAQ:AUTL) Receives Buy Rating from Needham & Company LLC
Autolus Therapeutics (NASDAQ:AUTL – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Needham & Company LLC in a report issued on Thursday,Benzinga reports. They presently have a $10.00 price objective on the stock. Other equities analysts also recently issued reports about the company. Wells Fargo & Company dropped their […]
Autolus Therapeutics (NASDAQ:AUTL – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Needham & Company LLC in a report issued on Thursday,Benzinga reports. They presently have a $10.00 price objective on the stock. Other equities analysts also recently issued reports about the company. Wells Fargo & Company dropped their […]
